報價延遲最少15分鐘:2025/08/12 21:16 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.27 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.56/-0.92
|
|
企業價值
1.40B
|
| 資產負債 |
|
每股賬面淨值
3.43
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
28.83M
|
|
每股收益
0.17
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/08/12 21:16 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to theclinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program. |
